Prostate-specific antigen levels in the United States: implications of various definitions for abnormal. - Wikidata - awgldk - TriplyDB

Prostate-specific antigen levels in the United States: implications of various definitions for abnormal.

Prostate-specific antigen levels in the United States: implications of various definitions for abnormal.

http://www.wikidata.org/entity/Q33989110

about

Shiftwork and prostate-specific antigen in the National Health and Nutrition Examination Survey Distribution of PSA velocity by total PSA levels: data from the Baltimore Longitudinal Study of Aging.The relation of serum parathyroid hormone and serum calcium to serum levels of prostate-specific antigen: a population-based study.Association of urinary phytoestrogen concentrations with serum concentrations of prostate-specific antigen in the National Health and Nutrition Examination Survey.Prostate-specific antigen testing across the spectrum of prostate cancer.Prostate specific antigen testing among the elderly--when to stop?Statin medications are associated with a lower probability of having an abnormal screening prostate-specific antigen result.Prostate biopsy for the interventional radiologist Prostate cancer screening and determining the appropriate prostate-specific antigen cutoff values.Mobile application-based Seoul National University Prostate Cancer Risk Calculator: development, validation, and comparative analysis with two Western risk calculators in Korean men Clinically localised prostate cancer.Macrophage inhibitory cytokine 1 biomarker serum immunoassay in combination with PSA is a more specific diagnostic tool for detection of prostate cancer.A Review on the Clinical Utility of PSA in Cancer Prostate Prevalence and Risk Factors of Prostate Cancer in Chinese Men with PSA 4-10 ng/mL Who Underwent TRUS-Guided Prostate Biopsy: The Utilization of PAMD Score Commentary: controversies in NICE guidance on prostate cancer.Biopsy follow-up of prostate-specific antigen tests.Overdiagnosis and overtreatment of early detected prostate cancer.Risk profiles and treatment patterns among men diagnosed as having prostate cancer and a prostate-specific antigen level below 4.0 ng/ml.Active surveillance for favorable-risk prostate cancer: what are the results and how safe is it?Five-year downstream outcomes following prostate-specific antigen screening in older men Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability.Screening for prostate cancer: Controversy? What controversy?Prostate cancer diagnosis in the new millennium: strengths and weaknesses of prostate-specific antigen and the discovery and clinical evaluation of prostate cancer gene 3 (PCA3).Prostate cancer screening and the management of clinically localized disease.Probability of an abnormal screening prostate-specific antigen result based on age, race, and prostate-specific antigen threshold.Nomogram to predict prostate cancer diagnosis on primary transrectal ultrasound-guided prostate biopsy in a contemporary series.A nomogram for prediction of prostate cancer on multi-core biopsy using age, serum prostate-specific antigen, prostate volume and digital rectal examination in Singapore.A direct comparison of the diagnostic accuracy of three prostate cancer nomograms designed to predict the likelihood of a positive initial transrectal biopsy.Atopy and prostate cancer: Is there a link between circulating levels of IgE and PSA in humans?Nomogram using transrectal ultrasound-derived information predicting the detection of high grade prostate cancer on initial biopsy.Prostate-specific antigen testing in men between 40 and 70 years in Brazil: database from a check-up program.Rebuttal: Should Canadians be offered systematic prostate cancer screening? NO.Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era.Prostate-specific antigen as a diagnostic tool: how useful and reliable is it?An integrative model of prostate cancer interaction with the bone microenvironment.A single mitochondrial DNA deletion accurately detects significant prostate cancer in men in the PSA 'grey zone'.Do prostate cancer nomograms give accurate information when applied to European patients?Nanoparticle-based targeted cancer strategies for non-invasive prostate cancer intervention.Incidence of initial local therapy among men with lower-risk prostate cancer in the United States.Cost implications of PSA screening differ by age.

P2860

Q28392746-EA5EDB38-6A21-48DA-8D23-92E7D8B0495E Q33783135-B10B3083-3DAF-45E8-818A-13DCDCFD2E98 Q33810503-3E5588A9-9F44-4396-8821-779F7F25A829 Q33862301-2C3A2397-D5DB-49F8-94E0-AB9B199EDAA5 Q34210163-AD26BB5E-A89D-4377-8028-AC6B1E940F58 Q34604893-C39AB5A5-7B29-4953-BC85-9F1715635B14 Q34626043-2034E9D3-841E-4F2E-A62B-D9085873A882 Q35019408-C77146C5-3C8A-4E30-9530-4D278A7B460C Q35022732-0D535E49-812F-4DC5-B6B2-130C93D693B5 Q35141766-271CED89-910B-46A0-8E30-4F1F88C7C473 Q35166972-23CE2060-99CC-4CB7-B017-99ED08F47EB3 Q35325174-F9132B0C-A1F3-47FC-A24D-4C02F11C2858 Q36084063-90D7A583-8DFD-400C-B88D-F8E525354149 Q36236472-3096541A-B127-4AFB-ACD8-A06702C7482F Q36496838-531E8DAF-F17E-4AD1-AD08-88828C09FF12 Q36567436-60E3C5BD-6840-4884-A106-4AE9F60AB268 Q36761279-3385E12C-44A2-4F4B-BD4B-9D5B38B3DC42 Q36837061-76FEE297-9F87-4E72-8328-418C67F3FF76 Q36946058-B3D1A8DC-0378-43EC-B06C-1BED0CA88725 Q37017183-CC7580FE-DB4F-4D4E-A45B-0E955CEF5B6F Q37104344-7365C7C9-A6C8-4679-B99F-A860106BC85D Q37225772-A8FB82ED-4695-4AD9-BC0C-A80E1790F3B3 Q37372813-56B31A63-1E17-4ADF-B212-D1E877249A0C Q37609671-339766F2-154C-48FB-935D-05BD6AAFF28B Q37619443-15181BF6-DAAF-40A0-93D1-C09122FAEBC1 Q38219393-DBED862F-7B6A-4228-949B-E77041493FC3 Q39377009-2BFF405A-DAEE-4E9B-8D00-8C7127B8C753 Q40014386-083A4CF0-1B45-4026-8977-4E6F4D026A8F Q40088352-43EAA16F-3968-492D-98EF-1819D3C8DE16 Q40149911-4D1501B7-BB9D-458F-8565-B92FE62B1718 Q40251884-917C87B5-E199-4E93-B304-1BD4185FC15E Q42414608-5485A0B8-2B17-4463-8C0C-C68C6E1E4F35 Q43421699-94DEC910-D3A8-465D-BD67-3667177439D7 Q45022751-98323560-483B-47A1-8595-AF801F403DAB Q47684232-428C3F6D-80BC-4978-BE36-87205F28F5B2 Q49719286-D8C3C5B2-574B-496A-B025-37C990304553 Q50675542-6406C135-F03A-4240-B39F-14B0C69C531F Q52718880-6AEDA7A9-F129-4D24-9F14-431C8741841A Q53864503-8AEF17A2-C342-41FA-AC83-7FBB03AF158A Q55032029-442317D6-4E93-4AB9-8607-7A37F0A1B3AA

P2860

Prostate-specific antigen levels in the United States: implications of various definitions for abnormal.

http://www.wikidata.org/entity/Q33989110

description

2005 nî lūn-bûn

@nan

2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Prostate-specific antigen leve ...... ious definitions for abnormal.

@ast

Prostate-specific antigen leve ...... ious definitions for abnormal.

@en

type

label

Prostate-specific antigen leve ...... ious definitions for abnormal.

@ast

Prostate-specific antigen leve ...... ious definitions for abnormal.

@en

prefLabel

Prostate-specific antigen leve ...... ious definitions for abnormal.

@ast

Prostate-specific antigen leve ...... ious definitions for abnormal.

@en

P1433

Q33989110-3FCD256E-A73E-4ECE-855F-2E07E05AEC5A

P1476

Q33989110-CF969B62-6637-46BB-B9BB-AC228C4BE72C

P2093

Q33989110-723E5D90-EBC5-48DF-8A1B-04D7DB0642D4

Q33989110-AF3A28C5-983C-4EB9-A4AE-CCCE033E802A

Q33989110-B2CAD847-2A22-4397-8EC2-164EAE5541C4

P2860

Q33989110-161F32F1-F6C9-4E22-8647-3222C15557A0

Q33989110-220B4CD6-AC21-4290-8A82-54970F488EE5

Q33989110-33EBC0BA-E60A-4A06-B312-6C8157182555

Q33989110-3DF66291-6196-419C-BEE1-DA0E1E719066

Q33989110-7B37D8F2-39EE-49C1-A2F1-4BEADC278F77

Q33989110-A497EE65-E728-473C-8EF4-BDA9E6E8125C

Q33989110-CF7E030F-3BAC-4370-8425-B8E5457CC45F

Q33989110-D11BD437-F678-44C5-8EE0-6A5B91A5E7CF

Q33989110-EF90D65F-7180-41C7-9976-1D3CF5C02815

P304

Q33989110-676335BB-71F7-4EAF-BD1F-E75DE3FFF2D9

P31

Q33989110-2B5E9EB7-0D0D-47E6-B8BD-6DB9FF26061F

P356

Q33989110-4EF2FA61-732D-42CA-991D-3E610E121D68

P407

Q33989110-E75C42A6-393F-469F-8CA8-2C62A924B1DB

P433

Q33989110-B1E564EB-0E40-43B7-A177-FAAE27B87055

P478

Q33989110-94B01521-2CB4-4897-B27A-5FFFFADB01E3

P577

Q33989110-C131301A-8344-4255-907A-3A6F07B5C336

P5875

Q33989110-6A82308D-D32D-4A4D-B873-F9630F94FFEF

P698

Q33989110-F0BC3B38-FB96-4711-9C3A-C90F002E0B0E

P921

Q33989110-96B2A65C-627D-42B6-8EBC-FA848452D796

P356

P1433

Journal of the National Cancer Institute

P1476

Prostate-specific antigen leve ...... ious definitions for abnormal.

@en

P2093

H Gilbert Welch

http://www.w3.org/2001/XMLSchema#string

Lisa M Schwartz

http://www.w3.org/2001/XMLSchema#string

Steven Woloshin

http://www.w3.org/2001/XMLSchema#string

P2860

Prostate cancers in men with low PSA levels--must we find them?

Prostate-specific antigen: current status.

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter.

Measurement of prostate-specific antigen in serum as a screening test for prostate cancer.

Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer.

Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.

Extended sector biopsy for detection of carcinoma of the prostate.

Prostate cancer detection in the prostate specific antigen range of 2.0 to 3.9 ng/ml: value of percent free prostate specific antigen on tumor detection and tumor aggressiveness.

Role of "saturation biopsy" in the detection of prostate cancer among difficult diagnostic cases.

P304

1132-1137

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJI205

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P577

2005-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7682737

http://www.w3.org/2001/XMLSchema#string

P698

16077071

http://www.w3.org/2001/XMLSchema#string

P921

Ameeriga Ütisriigiq